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OBJECTIVE — The aim of this study was to test whether being born small for gestational age
(SGA) has an impact on adiponectin and leptin levels and the IGF system in relation to insulin
sensitivity, taking into consideration the severity of growth restriction.
RESEARCH DESIGN AND METHODS — Serum levels of adiponectin, leptin, fasting
glucose,fastinginsulin(IF),thehomeostasismodelassessmentinsulinresistanceindex(HOMA-
IR),IGF-1,freeIGF-1,IGF-bindingprotein(IGFBP)-1and-3,totalcholesterol,HDLcholesterol,
LDL cholesterol, and triglycerides were evaluated in 57 children at age 4–10 years. Of these, 32
hadbeenbornappropriatesizeforgestationalage(AGA)and25SGA(14inthe3rdpercentile
and 11 in the 3rd–10th percentile).
RESULTS — The SGA 3rd–10th percentile children were already insulin resistant at prepu-
bertalage(IF39.616.8vs.2712pmol/l,P0.01,andHOMA-IR1.40.6vs.0.950.42
inSGAvs.AGAchildren,P0.05).TheirIGF-1andIGFBP-3concentrationsweresigniﬁcantly
lower than those in AGA children (160.4  66.2 vs. 207  66.8 g/l, P  0.05 and 2.3  0.4
vs.3.511.21mg/linSGAvs.AGAchildren,P0.01).TheSGA3rdpercentilechildrenhad
higher adiponectin (15.6  5.7 mg/l, P  0.05) and IGFBP-1 levels (113.5  33.9 g/l, P 
0.05) than AGA children (11.3  6.6 mg/l and 90.8  24.2 g/l, respectively) and lower IGF-1
and IGFBP-3 concentrations (162.6  68.4 g/l, P  0.05 and 2.4  0.7 mg/l, P  0.01). They
also had signiﬁcantly lower waist circumference (P  0.05). Leptin levels did not differ among
groups,butaninversecorrelationwithIGFBP-1(r0.55,P0.01)wasfoundinthepooled
SGA group.
CONCLUSIONS — Intrauterine growth restriction appears to affect the IGF axis at prepu-
bertal age, and its severity plays a role in insulin sensitivity.
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hanges in the secretion of and sen-
sitivity to the hormones insulin,
IGF-1, and IGF-binding proteins
(IGFBPs) during gestation or after may be
associated with metabolic syndrome in
adulthood (1). The IGF-1 in circulation is
bound to the IGFBP-3, which in turn
modulates IGF-1 availability. The data
generated from studies in IGFBP-3
transgenic mice clearly demonstrate
that IGFBP-3 plays a role in glucose ho-
meostasis, possibly by regulating free
IGF-1levelsintissues(2).Lowcirculating
levelsofserumIGF-1andIGFBP-1(3)are
considered to be implicated in impaired
glucose tolerance, elevated blood pres-
sure, and obesity. Low birth weight has
been associated with an increased risk of
obesity,insulinresistance,anddiabetesin
adulthood (4).
Adiponectin, the most abundant of
the “adipocytokines,” appears to exert
antidiabetic, antiatherogenic, and anti-
inﬂammatory activities. Low adiponectin
levels are observed in the metabolic syn-
drome and are considered to be an inde-
pendent risk factor for development of
type 2 diabetes later in life (5). Leptin,
which reﬂects body fat mass, has been
thought to play a role in the genesis of
metabolic syndrome and cardiovascular
disease (CVD). It is thought to be associ-
ated with insulin resistance, through in-
hibition of insulin secretion, and is
inverselyrelatedtoadiponectinlevels(6).
To our knowledge there have been no
reports of studies dealing with the relation-
ship between the IGF axis, adipocytokines,
and insulin resistance in prepubertal chil-
dren born small for gestational age (SGA).
In this study, we attempted to evaluate
serum adiponectin and leptin levels in re-
lation to components of the IGF system
and indexes of insulin resistance in
healthy prepubertal children born SGA,
taking into consideration the severity of
growth restriction at birth.
RESEARCH DESIGN AND
METHODS— The study included 57
prepubertal children aged 410 years
born either SGA (n  25) or appropriate
size for gestational age (AGA) (n  32)
between April 1997 and December 1998
at the University Hospital of Ioannina,
which hosts the majority (85%) of
births in a well-deﬁned geographical area
of northwestern Greece. The anthropo-
metric measures at birth were obtained
retrospectively by a chart review. All of
thestudychildrenwerebornbetweenthe
36thand40thweeksofgestation,withno
evidence of congenital malformations or
geneticdisorders.TheAGAchildrenwere
matchedwiththeSGAchildrenaccording
to age and sex. All of the subjects selected
for the study were to be nonobese, with
BMI 85th percentile, based on growth
charts speciﬁc for age and sex for Greek
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vated risk factor proﬁle in the higher
range of BMI (7). The Ethics Committee
of Ioannina University Hospital approved
the study protocol, and informed written
consent was obtained from the parents of
each child.
SGA was deﬁned as birth weight
10th percentile for gestational age. The
SGA children were divided into two sub-
groups based on the severity of growth
restriction: children with birth weight be-
tween the 3rd and 10th percentiles (n 
11) and children with birth weight 3rd
percentile (n  14). AGA was deﬁned as
birth weight between the 10th and 90th
percentiles for gestational age.
At the time of the study, BMI was es-
timated and BMI z scores speciﬁc for age
and sex were calculated. Body weight,
body height, head circumference, and
waist circumference as an indicator of
centralobesityweremeasuredusingtech-
niques described previously (8). Pubertal
stage was assessed by physical examina-
tion according to the criteria of Tanner
staging.
The parent of each child completed a
weekly food record for that child, from
which total energy intake, proteins, lip-
ids, and carbohydrates were calculated.
To estimate the effect of catch-up growth,
the SGA children were reclassiﬁed into
two additional subgroups according to
their corrected height standard deviation
scores (SDSs): actual height SDS  mid-
parental height SDS, where midparental
height for boys equals father’s height 
(mother’s height  13)/2 and for girls
equals mother’s height  (father’s
height  13)/2 (9,10). This gave one sub-
group with no catch-up growth (n  10),
comprising children with a corrected
heightof0SDS,andonesubgroupwith
catch-up growth (n  15), with a cor-
rected height of 0 SDS. SGA infants
were also classiﬁed into two groups, sym-
metrical (n  7) and asymmetrical (n 
18), according to their ponderal index
(birth weight [grams]  100/length at
birth in cubic centimeters).
Hormone and biochemical assays
Venous blood samples for laboratory
analysis were collected between 7:00 and
8:00 A.M.,after12-hovernightfasting.Se-
rum adiponectin levels were measured by
an enzyme-linked immunosorbent assay
(ELISA)usingakitfromPhoenixPharma-
ceuticals Inc. (EK-ADI-01; Belmont, CA).
The sensitivity of the adiponectin assay
was 0.40 mg/l. The intra- and interassay
coefﬁcients of variation (CVs) were 10
and 15%, respectively. Fasting insulin
(IF) levels were determined with an im-
munoenzymatic method (AxSYM ana-
lyzer; Abbott), and fasting glucose (GF)
concentrationsweremeasuredbytheglu-
cose oxidase method. IF and the ho-
meostasis model assessment for insulin
resistance (HOMA-IR, equal to IF [milli-
unitsperliter]GF[millimolesperliter]/
22.5) were chosen as measures of insulin
sensitivity (11). The IGFs and their bind-
ing proteins were determined by ELISA
using kits from Diagnostic Systems Labo-
ratories. The sensitivities for IGF-1, free
IGF-1, IGFBP-1, and IGFBP-3 were, re-
spectively, 0.01, 0.02, 0.025, and 0.04
g/l. The intra- and interassay CVs were
4.5 and 6.0% for IGF-1, 3.6 and 10.1%
for free IGF-1, 2.5 and 6.8% for IGFBP-1,
and 9.5 and 10.4% for IGFBP-3. Serum
leptin levels were measured by the ELISA
method using a kit from BioVandor Lab-
oratory Medicine (Modrice, Czech Re-
public). The sensitivity of the leptin assay
was 0.50 g/l. The intra- and interassay
CVs were 5 and 10%, respectively. Lipids
were analyzed in the Olympus AU 640
automatic analyzer (Olympus Diagnos-
tica, Hamburg, Germany). LDL choles-
terol was calculated using the Friedewald
formula.
Statistical analysis
Results are reported as means  SD and
range (minimum and maximum values).
The Mann-Whitney U test or Student’s t
testwasusedforvariablesdisplayingnon-
normal or normal distribution, respec-
tively. Simple linear regression analysis
was used to identify possible correlations
between variables. Statistical analyses
were performed using the StatView soft-
warepackageofSASInstitute(Cary,NC).
Differences were considered statistically
signiﬁcant at P  0.05.
RESULTS— The retrospective analy-
sis of the hospital neonatal records iden-
tiﬁed 70 children born SGA during the
20-month period, of which 47 were eligi-
ble to participate in the study and had
adequateperinatalinformationaboutges-
tational age, birth weight, and possible
risk factor for growth restriction. A fur-
ther 22 children were eliminated: for 6
contact details were inadequate; for 5 the
parents did not give consent; for 6 the
serumspecimenswereinappropriate;and
for 5 BMI was 85th percentile. The re-
maining25SGAchildrenwereenrolledin
the study. Risk factors for growth restric-
tion had been detected in 17 of the 25
SGA children, with hypertensive disease
of pregnancy being the most common (9
of17),followedbyplacentalinsufﬁciency
(3 of 17), low maternal weight gain dur-
ingpregnancy(3of17),andmultipleges-
tation (2 of 17). SGA with risk factors for
growth restriction were distributed
equally in the 3rd percentile subgroup
(n10)andthe3rd–10thpercentilesub-
group(n7)(NS).The32matchedcon-
trol subjects were selected from a sample
of 165 AGA children born at the hospital
duringthesameperiodwhowereinitially
contacted. All of the study children were
at Tanner stage I. No differences were
found in mean intake of calories, protein,
lipids, and carbohydrates between the
SGA and AGA groups, which were well
within the European recommended di-
etary allowances for sex and age (http://
www.euro.who.int/Document/WS_115_
2000FE_A.pdf). The mean daily calorie
intakes were 1,430, 1,450, and 1,470
kcal/day in the AGA, SGA 3rd percen-
tile,andSGA3rd–10thpercentilegroups,
respectively (NS).
Mean  SD values for the anthropo-
metricindexesofthesubjectsatbirthand
in the study period are depicted in Table
1. Children born SGA 3rd percentile
had lower body height (P  0.05) and
waist circumference (P  0.01) than the
AGA children (Table 1).
The GF levels were similar in all
groups and subgroups (Table 2), but in
thepooledSGAchildrentheIFconcentra-
tions and the HOMA-IR values were sig-
niﬁcantly higher than those in the AGA
children (P  0.05). These differences
were due mainly to the differences ob-
served between the 3rd–10th percentile
SGA subgroup and the AGA group. Se-
rum IGF-1 concentrations were lower in
the pooled SGA group (P  0.05) and in
both SGA subgroups than in the AGA
group, whereas free IGF-1 showed no
difference between groups (Table 2).
The IGFBP-3 levels were also lower in the
pooledSGAgroup(P0.001)andthetwo
subgroups compared with the AGA
group (Table 2). IGFBP-1 circulating
levels were signiﬁcantly higher only in
theSGA3rdpercentilesubgroup(P 
0.05) compared with the AGA group
(Table 2).
In the SGA 3rd percentile sub-
group, adiponectin concentrations were
signiﬁcantlyhigherthanthoseintheAGA
group and the SGA 3rd–10th percentile
subgroup (P  0.05) (Table 2). Leptin
concentrations did not differ signiﬁcantly
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for these to be higher in the SGA 3rd–
10thpercentilesubgroupthanintheAGA
group (Table 2). No signiﬁcant difference
was observed in the serum total choles-
terol, HDL cholesterol, LDL cholesterol,
and triglyceride levels among the pooled
SGA group or their two subgroups and
the AGA control group (Table 2).
In the pooled SGA group adiponectin
was found to be negatively associated
with BMI, waist circumference, body
weight and body height, IGF-1, and free
IGF-1 (Table 3). In the AGA group, only
waist circumference was negatively asso-
ciated with adiponectin. No correlation
with the other parameters was observed.
A positive association of leptin with the
insulin resistance indexes IF and HOMA-
IR, BMI, and waist circumference was
found in both the pooled SGA and the
AGA children. A negative association be-
tween leptin and adiponectin was seen
only in the pooled SGA group (Table 3).
In addition, circulating IGFBP-1 levels
andfreeIGF-1concentrationswerefound
to be inversely correlated in the pooled
SGA group only (R  0.72, P 
0.0001).
SGA children were further analyzed
according to catch-up growth. The two
subgroups, with and without catch-up
growth,didnotdifferforageorsex.Eight
Table 2—Fasting blood glucose, insulin, HOMA-IR, leptin, adiponectin, IGF-1, free IGF-1, IGFBP-1 and -3, and lipids at the time of study in
children of prepubertal age born AGA or SGA (<10th percentile) and SGA subgroups (3rd–10th and <3rd percentile)
AGA Pooled SGA SGA 3rd–10th percentile SGA 3rd percentile
n 32 25 11 14
GF (mmol/l) 4.65  0.4 (3.9–5.5) 4.58  0.5 (3.2–5.4) 4.67  0.3 (4.1–5.1) 4.52  0.6 (3.2–5.4)
IF (pmol/l) 27.0  12 (6–60) 36.6  20.4 (12–95.4)* 39.6  16.8 (12–63.6)** 34.8  23.4 (12–95.2)
HOMA-IR 0.95  0.42 (0.18–1.85) 1.3  0.8 (0.3–4.1)* 1.4  0.6 (0.4–2.2)* 1.2  1 (0.3–4.1)
IGF-1 (g/l) 207  66.8 (65–332) 161.6  66 (52–302)* 160.4  66.2 (52–277)* 162.6  68.4 (63–302)*
Free IGF-1
(g/l) 0.87  0.78 (0.01–2.4) 0.61  0.34 (0.2–1.2) 0.64  0.37 (0.2–1.2) 0.58  0.33 (0.2–1.17)
IGFBP-3 (mg/l) 3.51  1.21 (0.85–5.7) 2.36  0.58 (1.3–3.6)*** 2.3  0.4 (1.4–3.1)** 2.4  0.7 (1.3–3.6)**
IGFBP-1 (g/l) 90.8  24.2 (46.2–137.9) 107.8  40.1 (45.2–194) 100.5  47.5 (45.2–194) 113.5  33.9 (67–189)*
Adiponectin
(mg/l) 11.3  6.6 (3.9–18.3) 13.3  6.7 (2.6–25.2) 12.5  7 (2.6–22.5)† 15.6  5.7 (5.5–25.2)*
Leptin (g/l) 8.47  7.36 (1.8–31.4) 11.4  12.9 (2.2–50) 13.9  16.2 (2.2–50) 9.4  9.8 (2.2–30.5)
Total cholesterol
(mmol/l) 4.4  0.59 (3.15–5.5) 4.3  0.62 (3.23–5.18) 4.37  0.64 (3.23–5.15) 4.25  0.62 (3.36–5.18)
HDL cholesterol
(mmol/l) 1.28  0.15 (0.9–1.8) 1.29  0.12 (0.82–1.68) 1.29  0.1 (0.82–1.65) 1.29  0.28 (0.93–1.68)
Triglycerides
(mmol/l) 0.75  0.31 (0.56–1.63) 0.76  0.3 (0.55–1.5) 0.82  0.35 (0.55–1.5) 0.68  0.13 (0.62–1.46)
LDL cholesterol
(mmol/l) 2.77  0.56 (1.34–3.88) 2.6  0.54 (1.2–3.7) 2.66  0.5 (1.26–3.4) 2.59  0.59 (1.2–3.7)
DataaremeansSD(ranges).*P0.05,**P0.01,and***P0.001forcomparisonwiththeAGAgroup.†P0.05forcomparisonbetweentheSGA3rd–10th
percentile and the SGA 3rd percentile subgroups.
Table1—Anthropometricindexesatbirthandatthetimeofstudyintwogroupsofprepubertalchildren,bornAGAorSGA(<10thpercentile)
plus SGA subgroups (3rd–10th and <3rd percentile)
AGA Pooled SGA SGA 3rd–10th percentile SGA 3rd percentile
n 32 25 11 14
At birth
Sex (male) 18 13 6 7
Gestational age (weeks) 37.3  1.1 37  1.2 36.9  1.3 37.1  1.6
Birth weight (g) 3,375  407 1,880  490* 1,995  430* 1,750  422*
Crown-to-heel length (cm) 51.4  2 44.8  4.6* 45.5  4.2* 43.7  5.1*
Head circumference (cm) 34.6  1.3 31  2.8* 31  2.6* 30.5  2.9*
Ponderal index (g/cm
3) 2.48  0.22 2.15  0.2* 2.1  0.2* 2.2  0.2*
At the time of study
Age (years) 6.59  1.6 6.2  2.9 6.36  1.6 6.04  2.3
Body weight (kg) 26  6.2 25.4  6 25.6  6.3 25  6.7
Body height (cm) 121.9  13.3 118  9.2 121.4  11.2 114.5  15.5†
Waist circumference (cm) 60.6  7.4 58.4  9.6 59.6  10.1 53.8  8.8***
BMI (kg/m
2) 18.4  2 17.4  3.6 17.7  3.4 17.6  3.9
BMI SDS 0.18  0.43 0.17  0.62 0.17  0.6 0.16  0.64
Values are means  SD. *P  0.0001, ***P  0.01, and †P  0.05 for comparison with the AGA group.
Adipocytokines and growth factors in SGA children
716 DIABETES CARE, VOLUME 32, NUMBER 4, APRIL 2009children with catch-up growth in height
had birth weight 3rd percentile and
seven had birth weight between the 3rd
and 10th percentiles (NS). SGA children
who did not exhibit catch-up growth had
higher adiponectin and IGFBP-1 levels
thanAGAchildren(16.26.5vs.11.3
6 mg/l, P  0.05 and 128  44.7 vs.
90.824.2g/l,P0.01,respectively).
Children who exhibited catch-up growth
had a tendency to have higher leptin lev-
els only (13.8  1.4 vs. 8.47  7.36 g/l,
P  0.07). Both SGA catch-up subgroups
had lower IGFBP-3 levels than the AGA
group (2.2  0.6, 2.46  0.5, vs. 3.5 
1.2 mg/l, respectively, P  0.01). No dif-
ferences were observed in the rest of the
parameters examined.
After taking into consideration pro-
portionality in the SGA children, the only
differencefoundwasthelowerIGF-1and
IGFBP-3 levels in both subgroups, sym-
metrical or asymmetrical SGA, compared
with the AGA group. No distinct differ-
ences in any other of the parameters ex-
amined were found, either between the
two SGA proportionality subgroups or
between the subgroups and the AGA
group. Four asymmetrical SGA children
had birth weight 3rd percentile and
three had birth weight between the 3rd
and 10th percentile.
CONCLUSIONS — Reduced plasma
IGF-1 and IGFBP-3 levels are reported in
insulin-dependent diabetes and may rep-
resent a state of partial growth hormone
resistance in patients with poorly con-
trolled diabetes (12). Low serum IGF-1
levels are also associated with the devel-
opment of CVD and are considered to re-
ﬂect a higher risk for insulin resistance
and later appearance of diabetes (1). In
the present study, IGF-1 and IGFBP-3
were found to be lower and If and the
HOMA-IR index were higher in the
pooled SGA group than in the AGA chil-
dren in the prepubertal phase. These dif-
ferences were more pronounced in the
SGA children born between the 3rd and
10thpercentiles.IGF-1isbelievedtohave
insulin-like actions in ﬁne-tuning insulin
sensitivity (2). The effects of IGF-1 on in-
creasing insulin sensitivity have been
demonstrated in normal subjects during
euglycemicclamps(13).Hence,thelower
total IGF-1 levels seen in the SGA 3rd–
10th percentile study group could be re-
sponsible for the higher IF levels found
with normal fasting glucose levels. The
lowerIGF-1levelscouldbeafactorforan
increased risk of development of diabetes
in later life.
Higher insulin concentrations at
baseline were also observed in a study of
25-year-old subjects born with intrauter-
ine growth retardation (14). An oral glu-
cose tolerance test for those subjects
showed that there was decreased insulin-
stimulated glucose uptake, leading to the
suggestion that intrauterine growth retar-
dationexertsanindependenteffectonin-
sulin sensitivity (14). Although glucose
tolerance tests were not done in the
present study, the higher If levels and
HOMA-IR with GF similar to those for
AGAchildrenmaysuggestanearlystartof
insulin resistance in the SGA study chil-
dren, especially in the 3rd–10th percen-
tile subgroup.
IGFBP-1 concentrations showed no
differences between the AGA group and
the SGA 3rd–10th percentile subgroup
but were higher in the SGA 3rd percen-
tile subgroup. There is experimental evi-
dence that IGFBP-1 can ﬁnely regulate
bioactivity of IGF-1 and is involved in
glucose homeostasis (2,13). An inverse
relationship between IGFBP-1 and free
IGF-1 has been reported in normal hu-
mansubjectsandwasfoundinthepooled
SGA group of the present study, although
free IGF-1 levels were not higher in the
SGA 3rd percentile subgroup, whereas
theirglucoseandinsulinlevelswerecom-
parable with those of the AGA group. The
higher IGFBP-1 levels in the SGA 3rd
percentilesubgroupmightbeaprotective
factor for diabetes, whereas this may not
be so for the SGA 3rd–10th percentile
subgroup,whichalsohadhigherIFlevels.
The SGA 3rd percentile children had
lower waist circumference, which may
mean that they had a leaner stature than
the AGA children, thus having an addi-
tionalprotectingfactor,becausewaistcir-
cumference is regarded as an index of
abdominal fat and the degree of central
obesity (7) and has been associated with
insulin sensitivity. Those children were
also shorter. Lower height has been asso-
ciated with higher IGFBP-1 in studies
with adults (15).
Adiponectin has been reported to be
closely related to insulin sensitivity
(5,16,17). Yamamoto et al. (17) observed
in adults that when adiponectin levels
Table 3—Correlations between adiponectin or leptin and growth factors, anthropometric parameters, or insulin sensitivity index in AGA and
SGA (<10th percentile) children
Adiponectin versus:
IGF-1 Free IGF-1 BMI
Waist
circumference Body weight Body height
AGA NS NS NS R  0.40 NS NS
NS NS NS P  0.03 NS NS
Pooled SGA R  0.44 R  0.48 R  0.40 R  0.47 R  0.50 R  0.55
P  0.05 P  0.02 P  0.05 P  0.05 P  0.012 P  0.005
Leptin versus:
IF HOMA-IR BMI
Waist
circumference Adiponectin IGFBP-1
AGA R  0.67 R  0.66 R  0.75 R  0.67 NS NS
P  0.0001 P  0.0001 P  0.0001 P  0.0001 NS NS
Pooled SGA R  0.50 R  0.48 R  0.70 R  0.73 R  0.41 R  0.55
P  0.01 P  0.05 P  0.0001 P  0.0001 P  0.05 P  0.01
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addition, strong inverse correlations be-
tweenadiponectinlevelsandBMIorwaist
circumference have been reported in
adults (16,17). In the present study, an
inverse correlation of adiponectin with
waist circumference was found both in
the pooled SGA group and in the AGA
group, indicating a strong relationship
betweenthisproteinandabdominalfator
central obesity, independent of birth
weight.However,theinverserelationship
of adiponectin levels with BMI, body
weight, and body height that were ob-
served only in the pooled SGA group may
be explained by differences in the growth
process in SGA children. The lower adi-
ponectin concentrations in the SGA 3rd–
10th percentile subgroup in relation to
the SGA 3rd percentile subgroup may
be due to their differences in height and
waist circumference. The fact that the
subgroup of SGA 3rd percentile chil-
dren, which had higher IGFBP-1 levels,
wasalsofoundtohavehigheradiponectin
levels than the AGA control children may
reﬂect their capability to maintain higher
insulin sensitivity than the SGA 3rd–10th
percentile subgroup. These ﬁndings
could be interpreted as additional protec-
tive factors for this subgroup with respect
to insulin resistance.
Withregardtoleptin,therewasaten-
dency for higher levels in the pooled SGA
group and even more so in the SGA 3rd–
10th percentile subgroup, but the differ-
ences from the AGA group were not
statisticallysigniﬁcant.Itappearsthatthis
hormone is related mainly to current
weightratherthantheSGAstatusatbirth,
and a very strong relationship was found
in both the AGA and the SGA study
groups between leptin levels and current
BMI.
Catch-upgrowthhasbeenpostulated
to be associated with insulin resistance
and increased risk for type 2 diabetes
(18,19). To clarify the effects of catch-up
growth in the SGA children of the present
study, an analysis was made after classify-
ing SGA children into two subgroups ac-
cording to catch-up growth in height.
Children without catch-up growth had
higher levels of adiponectin and IGFBP-1
compared with the AGA children, imply-
ing that this subgroup of SGA children
may have higher insulin sensitivity than
the SGA subgroup who exhibited
catch-up growth and who had adiponec-
tin levels comparable to those of the con-
trol subjects. These results are in
agreement with those reported for pre-
pubertal SGA children, in whom a hyper-
insulinemic-euglycemic clamp study was
performed to determine insulin sensitiv-
ity (18). Cianfarani et al. (10) estimated
catch-up growth by calculating the cor-
rected height and Lopez-Bermejo et al.
(20) by considering the BMI SDS. Both
reportedhigheradiponectinlevelsinSGA
groups not experiencing catch-up growth
in height or BMI, respectively (10,20),
whichisinagreementwiththeﬁndingsof
the present study. The trend for higher
leptin levels in the SGA subgroup who
exhibited catch-up growth is in agree-
ment with the ﬁndings of other studies,
which showed that catch-up growth after
intrauterine growth retardation was asso-
ciated with increased leptin levels (21).
Fasting insulin and leptin levels have
been reported to correlate inversely with
IGFBP-1 (22). One of the suggested
mechanisms is that higher body fat could
lead to elevation of leptin and insulin re-
sistance and to a secondary hyperinsulin-
emia, which in turn suppresses the
IGFBP-1 levels (22). This appears to ap-
ply in the SGA 3rd–10th percentile sub-
group. Inverse correlation between leptin
and IGFBP-1 or adiponectin was also
found in the pooled SGA group. In addi-
tion,aninverserelationshipwasobserved
between leptin and adiponectin in the
pooled SGA group. The lower adiponec-
tin and higher leptin levels found in the
SGA 3rd–10th percentile subgroup in
comparison with the SGA 3rd percen-
tile subgroup suggest additional factors
for insulin resistance in this subgroup.
Thenolaetal.(23)reportedthatSGAchil-
dren at the age of 12 years had levels of
totalcholesterolinthehighnormalrange,
whereas other researchers found no dif-
ference in the lipid proﬁle in 10-year-old
SGA children, in accordance with our re-
sults (24).
The classiﬁcation of the SGA children
into subgroups according to the severity
of growth restriction, as was done in the
present study, appears to unveil distinc-
tive differences, both between the sub-
groups and in comparison with the AGA
control subjects, with regard to most of
the parameters examined. A further clas-
siﬁcation according to the catch-up
growthpatternrevealeddistinctivediffer-
ences only in adiponectin and IGFBP-1
levelsbetweenthetwogroupsofSGAand
the AGA children. Some investigators
supportthehypothesisthathyperinsulin-
emiaprecedesthedevelopmentofinsulin
resistance and perhaps even the develop-
ment of obesity (25). If this hypothesis
proves correct, the hyperinsulinemia ob-
served in the SGA 3rd–10th percentile
subgroup is an early predictor for devel-
opment of insulin resistance and for the
subsequent development of diabetes.
Thus, SGA children with birth weight be-
tween the 3rd and 10th percentiles with
catch-up growth in height appear to be at
a greater risk for insulin resistance, with
adverse consequences for their later life.
However, the possibility that this sub-
group of SGA children may exhibit later
adaptation against insulin resistance, i.e.,
a rise in adiponectin, that the more se-
verely growth-restricted children exhib-
ited earlier in life cannot be excluded.
Until more data are available, continued
long-term monitoring is necessary for
both subgroups of SGA children.
In summary, the mechanism for de-
veloping an abnormal metabolic proﬁle
and the appearance of insulin resistance
are complex processes and may be of var-
ious etiologies in the different subgroups
of children born SGA. Intrauterine pro-
gramming of the adipose tissue and the
IGF axis could inﬂuence insulin sensitiv-
ityandconsequentlytheriskofmetabolic
syndrome and CVD. Catch-up growth in
height also appears to play a role in mod-
ulating the metabolic proﬁle even at pre-
pubertal age.
Acknowledgments— No potential conﬂicts
of interest relevant to this article were reported.
References
1. Holt RI: Fetal programming of the growth
hormone-insulin-like growth factor axis.
Trends Endocrinol Metab 13:392–397,
2002
2. Murphy L: The role of the insulin-like
growth factors and their binding protein
in glucose homeostasis. Exp Diabetes Res
4:213–224, 2003
3. SandhuMS,HealAH,GibsonMJ,Cruick-
shank JK, Dunger DB, Wareman NJ: Cir-
culating concentrations of insulin like
growth factor I and development of glu-
cose intolerance: a prospective observa-
tional study. Lancet 359:1740–1745,
2002
4. Levy-Marchal C, Jaquet D: Long-term
metabolic consequences of being born
small for gestational age. Pediatr Diabetes
4:147–153, 2004
5. WeyerC,FunahashiT,TanakaS,HottaK,
Matzuzawa Y, Pratley RE, Tatarani PA:
Hypoadiponectemia in obesity and type 2
diabetes:closeassociationwithinsulinre-
sistanceandhyperinsulinaemia.JClinEn-
docrinol Metab 86:1930–1935, 2001
6. Havel PJ, Sechon IV: Lipid modulators of
Adipocytokines and growth factors in SGA children
718 DIABETES CARE, VOLUME 32, NUMBER 4, APRIL 2009islet function of energy balance and car-
bohydrate/lipid metabolism. Diabetes 53:
5143–5151, 2004
7. Katzmarzyk PT, Srinivasan SR, Chen W,
Malina R, Bouchard C, Berenson GS:
Body mass index, waist circumference
and clustering of cardiovascular disease
risk factors in a biracial sample of chil-
dren and adolescents. Pediatrics 114:
198–205, 2004
8. Evagelidou EN, Kiortsis DN, Bairaktari
ET, Giapros VI, Cholevas VK, Tzallas CS,
AndronikouSK:Lipidproﬁle,glucoseho-
meostasis, blood pressure and obesity-
anthropometric markers in macrosomic
offspring of nondiabetic mother. Diabetes
Care 29:1197–1201, 2006
9. TannerJM,GoldsteinH,WhitehouseRH:
Standardsforchildren’sheightatages2–9
years allowing for height of parents. Arch
Dis Child 45:755–762, 1970
10. Cianfarani S, Martinez CH, Maiorana A,
Scire ` G, Spadoni GL, Boemi S: Adiponec-
tin levels are reduced in children born
small for gestational age and are inversely
related to postnatal catch-up growth.
J Clin Endocrinol Metab 89:1346–1351,
2004
11. Gungor N, Saad R, Janosky J, Arslanian S:
Validation of surrogate estimates of insu-
lin sensitivity and insulin secretion in
children and adolescents. J Pediatr 144:
47–55, 2004
12. Cohen RM, Abplanalp WA: Resistance of
growth hormone secretion to somatosta-
tin in men with type I diabetes mellitus.
Diabetes 40:1251–1258, 1991
13. HussainMA,SchmitzO,MengelA,Keller
A,ChristiansenJS,ZapfJ,FroeschER:In-
sulin-like growth factor I stimulates lipid
oxidation, reduces protein oxidation, and
enhances insulin sensitivity in humans.
J Clin Invest 92:2249–2256, 1993
14. Jaquet D, Gaboriau A, Czernichow P,
Levy-Marchal C: Insulin resistance early
in adulthood in subjects born with intra-
uterinegrowthretardation.JClinEndocri-
nol Metab 85:1401–1406, 2000
15. Hong Y, Brismar K, Hall K, Pederson ML,
de Faire U: Associations between insulin-
like growth factor-I (IGF-I), IGF-binding
protein-1, insulin and other metabolic
measures after controlling for genetic in-
ﬂuences:resultsfrommiddle-agedandel-
derlymonozygotictwinsJEndocrinol153:
251–257, 1997
16. CnopM,HavelPJ,UtzschneiderKM,Carr
DB, Sinha MK, Boyko EJ, Retzlaff BM,
Knopp RH, Brunzell JD, Kahn SE: Rela-
tionship of adiponectin to body fat distri-
bution, insulin sensitivity and plasma
lipoproteins. Diabetologia 46:459–469,
2003
17. Yamamoto Y, Hiroshi H, Saito I, Tomita
M, Taniyama M, Matsubara K, Okazaki Y,
Ishii T, Nishikai K, Saruta T: Correlation
of the adipocyte-derived protein adi-
ponectin with insulin resistance index
and serum high-density lipoprotein-cho-
lesterol,independentofbodymassindex,
in the Japanese population. Clin Sci 103:
137–142, 2002
18. Veening MA, Van Weissenbrugh MM,
Van de Waal HAD: Glucose tolerance, in-
sulin sensitivity and insulin secretion in
children born small for gestational age.
J Clin Endocrinol Metab 87:4657–4661,
2002
19. Ong KK, Petry CJ, Emmett PM, Sandhu
MS, Kiess W, Hales CN, Ness AR, Dunger
DB: Insulin sensitivity and secretion in
normal children related to size at birth,
postnatal growth, and plasma insulin-like
growth factor-I levels. Diabetologia
47:1064–1070, 2004
20. Lopez-Bermejo A, Casano-Sancho P, Fer-
nadez-Real JM, Kihara S, Funahashi T,
Rodriguez-Hierro F, Ricart W, Ibanez L:
Both intrauterine growth restriction and
postnatal growth inﬂuence childhood se-
rum concentrations of adiponectin. Clin
Endocrinol (Oxf) 61:544–552, 2004
21. Jaquet D, Leger J, Tabone MD, Czerni-
chow P, Levy-Marchal C: High serum
leptin concentrations during catch-up
growth of children born with intrauterine
growth retardation. J Clin Endocrinol
Metab 84:1949–1953, 1999
22. Liew CF, Wise SD, Yeo KP, Lee KO: Insu-
lin-likegrowthfactorbindingprotein-1is
independentlyaffectedbyethnicity,insu-
lin sensitivity, and leptin in healthy glu-
cose-tolerantyoungmen.JClinEndocrinol
Metab 90:1483–1488, 2005
23. ThenolaS,MartikainenA,RahialaE,Her-
rgard E, Halonen P, Voutilainen R: Serum
lipid concentrations and growth charac-
teristics in 12-year-old children born
small for gestational age. Pediatr Res 48:
623–628, 2000
24. Decsi T, Erhardt E, Marcus A, Burus I,
Molnar D: Plasma lipids, phospholipid
fatty acids and indices of glycaemia in 10-
year old children born as small-for-gesta-
tional-age or preterm infants. Acta
Paediatr 88:500–504, 1999
25. Odeleye OE, de Courten M, Pettit DJ, Ra-
vussin E: Fasting hyperinsulinemia is a
predictor of increased body weight gain
and obesity in Pima Indian children. Dia-
betes 46:1341–1345, 1997
Challa and Associates
DIABETES CARE, VOLUME 32, NUMBER 4, APRIL 2009 719